Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors

Human papillomavirus positive (HPV(+)) tonsillar and base of tongue squamous cell carcinoma (TSCC/BOTSCC) have a favorable outcome, but upon relapse, survival is poor and new therapeutical options are needed. Recently, we found synergistic effects by combining the food and drug administration approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostopoulou, Ourania N., Zupancic, Mark, Pont, Mariona, Papin, Emma, Lukoseviciute, Monika, Mikelarena, Borja Agirre, Holzhauser, Stefan, Dalianis, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320646/
https://www.ncbi.nlm.nih.gov/pubmed/35891353
http://dx.doi.org/10.3390/v14071372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320646/
https://www.ncbi.nlm.nih.gov/pubmed/35891353
http://dx.doi.org/10.3390/v14071372

Ejemplares similares